Theravance Biopharma (TBPH) Earnings Date & Reports
Theravance Biopharma Inc is a biopharmaceutical company focused on the development and commercialization of medicines to improve patients lives... Show more
TBPH is expected to report earnings to fall 160.00% to 5 cents per share on August 05
Q2'26
Est.
$0.06
Q1'26
Missed
by $0.07
Q4'25
Beat
by $0.15
Q3'25
Beat
by $0.20
Q2'25
Beat
by $0.41
The last earnings report on May 07 showed earnings per share of -10 cents, missing the estimate of -2 cents. With 364.00K shares outstanding, the current market capitalization sits at 875.90M.